Taro Pharmaceutical Indus Stock (NYSE:TARO), Quotes and News Summary

Q: What sector and industry does Taro Pharmaceutical Indus (TARO) operate in?

Taro Pharmaceutical Indus is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.

Taro Pharmaceutical Indus Stock (NYSE: TARO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 51.161K
Day Range	- - -
52 Wk Range	24.220 - 45.760
Market Cap	$1.586B
P/E Ratio	34.582
Dividend Yield	-
Exchange	NYSE
RSI	52
Short Interest	0.49%
Days to Cover	1.27

Recent News

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Lisa Levin

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical produc...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Taro Pharmaceutical Indus (TARO) stock?

You can purchase shares of Taro Pharmaceutical Indus (NYSE: TARO) through any online brokerage.

View our list of the best stock brokerages.

Who are Taro Pharmaceutical Indus's (TARO) competitors?

There are no as such competitors for Taro Pharmaceutical Indus.

What is the target price for Taro Pharmaceutical Indus (TARO) stock?

The latest price target for Taro Pharmaceutical Indus (NYSE: TARO) was reported by HC Wainwright & Co. on Thursday, January 18, 2024. The analyst firm set a price target for 43.00 expecting TARO to rise to within 12 months (a possible 1.92% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Taro Pharmaceutical Indus (TARO)?

The stock price for Taro Pharmaceutical Indus (NYSE: TARO) is $42.19 last updated April 18, 2024 at 4:01 PM EDT.

Does Taro Pharmaceutical Indus (TARO) pay a dividend?

A quarterly cash dividend of $12.81 per share of Class A Common Stock. The quarterly cash dividend was payable on December 28, 2018 to stockholders of record on December 10, 2018.

When is Taro Pharmaceutical Indus (NYSE:TARO) reporting earnings?

Taro Pharmaceutical Indus’s Q4 earnings are confirmed for Tuesday, May 21, 2024.

Is Taro Pharmaceutical Indus (TARO) going to split?

There is no upcoming split for Taro Pharmaceutical Indus.

What sector and industry does Taro Pharmaceutical Indus (TARO) operate in?

Taro Pharmaceutical Indus is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.